TRAPANI, DARIO
TRAPANI, DARIO
Universita' degli Studi di MILANO
Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021
2022 D. Trapani, G. Curigliano
Adjuvant treatment of early male breast cancer
2020 C. Corti, E. Crimini, C. Criscitiello, D. Trapani, G. Curigliano
Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors
2021 E. Yekedüz, D. Trapani, W. Xu, E.G. de Vries, C. Labaki, B. Gyawali, S. Gulati, C. Nabhan, G. Utkan, G. Curigliano, T.K. Choueiri, Y. Ürün
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis
2021 D. Trapani, S. Gandini, C. Corti, E. Crimini, F. Bellerba, I. Minchella, C. Criscitiello, P. Tarantino, G. Curigliano
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review
2021 D. Trapani, F. Giugliano, J. Uliano, V.A.A. Zia, A. Marra, G. Viale, E. Ferraro, A. Esposito, C. Criscitiello, P. D'Amico, G. Curigliano
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
2021 B. Gyawali, E.G.E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G. Zarkavelis, C. Zielinski, P. Zygoura, N.I. Cherny
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
2020 P. Tarantino, D. Trapani, G. Curigliano
COVID-19 vaccines in patients with cancer
2021 D. Trapani, G. Curigliano
Distribution of the workforce involved in cancer care: a systematic review of the literature
2021 D. Trapani, S.S. Murthy, M. Boniol, C. Booth, V.C. Simensen, M.K. Kasumba, R. Giuliani, G. Curigliano, A.M. Ilbawi
Entinostat for the treatment of breast cancer
2017 D. Trapani, A. Esposito, C. Criscitiello, L. Mazzarella, M. Locatelli, I. Minchella, S. Minucci, G. Curigliano
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
2020 E. De Azambuja, D. Trapani, S. Loibl, S. Delaloge, E. Senkus, C. Criscitiello, P. Poortman, M. Gnant, S. Di Cosimo, J. Cortes, F. Cardoso, S. Paluch-Shimon, G. Curigliano
European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis : From ethics to results through the understanding of communication and interaction flows
2020 A. Passaro, G. Mackenzie, M. Lambertini, G. Morgan, S. Zimmermann, P. Garrido, G. Curigliano, D. Trapani
Evaluating triptorelin as a treatment option for breast cancer
2019 E. Ferraro, D. Trapani, E. Marrucci, G. Curigliano
Evolution of low HER2 expression between early and advanced-stage breast cancer
2022 P. Tarantino, S. Gandini, E. Nicolo, P. Trillo, F. Giugliano, P. Zagami, G. Vivanet, F. Bellerba, D. Trapani, A. Marra, A. Esposito, C. Criscitiello, G. Viale, G. Curigliano
Expression of tumor-associated antigens in breast cancer subtypes
2020 G. Curigliano, V. Bagnardi, M. Ghioni, J. Louahed, V. Brichard, F.F. Lehmann, A. Marra, D. Trapani, C. Criscitiello, G. Viale
Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendations
2021 E. Nicolò, D. Trapani, P.P.M. Berton Giachetti, P. Zagami, G. Curigliano
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?
2021 F. Giugliano, E. Crimini, P. Tarantino, P. Zagami, J. Uliano, C. Corti, D. Trapani, G. Curigliano, P.A. Ascierto
Genomic analysis of circulating tumor DNA to predict endocrine resistance and clonal evolution in patients with prostate cancer : clinical perspectives and research opportunities
2016 D. Trapani, G. Curigliano